ArticleMolecular cancer therapeutics2024

Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.

Mason McCrury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.